Gain-of-function mutation of tristetraprolin impairs negative feedback control of macrophages in vitro yet has overwhelmingly anti-inflammatory consequences in vivo
The mRNA-destabilizing factor tristetraprolin (TTP) binds in a sequence-specific manner to the 3' untranslated regions of many proinflammatory mRNAs and recruits complexes of nucleases to promote rapid mRNA turnover. Mice lacking TTP develop a severe, spontaneous inflammatory syndrome character...
Main Authors: | O'Neil, JD, Ross, EA, Ridley, ML, Ding, Q, Tang, T, Rosner, DR, Crowley, T, Malhi, D, Dean, JL, Smallie, T, Buckley, CD, Clark, AR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Microbiology
2017
|
Similar Items
-
Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression
by: Ross, E, et al.
Published: (2016) -
Has Humankind Overwhelmed Nature’s Agency?
by: Williams James
Published: (2022-12-01) -
Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin
by: Tina Tang, et al.
Published: (2017-06-01) -
Role of Tristetraprolin in the Resolution of Inflammation
by: Peter Rappl, et al.
Published: (2021-01-01) -
The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.
by: Tchen, C, et al.
Published: (2004)